Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · IEX Real-Time Price · USD
3.750
+0.070 (1.90%)
At close: May 2, 2024, 4:00 PM
3.950
+0.200 (5.33%)
After-hours: May 2, 2024, 7:57 PM EDT
Eton Pharmaceuticals Revenue
In the year 2023, Eton Pharmaceuticals had annual revenue of $32.64M with 42.60% growth. Revenue in the quarter ending December 31, 2023 was $8.31M, a -9.13% decrease year-over-year.
Revenue (ttm)
$32.64M
Revenue Growth
+42.60%
P/S Ratio
2.95
Revenue / Employee
$1,088,067
Employees
30
Market Cap
96.20M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 32.64M | 9.75M | 42.60% |
Dec 31, 2022 | 22.89M | -441.00K | -1.89% |
Dec 31, 2021 | 23.33M | 23.29M | 59,725.64% |
Dec 31, 2020 | 39.00K | -920.00K | -95.93% |
Dec 31, 2019 | 959.00K | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
111, Inc. | 2.11B |
OptiNose | 70.99M |
BrainsWay | 31.79M |
Aclaris Therapeutics | 31.25M |
Curis | 10.02M |
Cue Biopharma | 5.49M |
Armata Pharmaceuticals | 4.53M |
Milestone Pharmaceuticals | 1.00M |
ETON News
- 1 day ago - Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 2 days ago - Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) - GlobeNewsWire
- 3 days ago - Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 - GlobeNewsWire
- 5 weeks ago - Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE - Accesswire
- 5 weeks ago - Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria - GlobeNewsWire
- 7 weeks ago - Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation - GlobeNewsWire